Cholesterol-functionalized carvedilol-loaded PLGA nanoparticles: anti-inflammatory, antioxidant, and antitumor effects
Source abstract
Abstract
Abstract The inflammation has been identified as factor of tumor progression, which has increased the interest and use of molecules with anti-inflammatory and antioxidant activities in the cancer treatment. In this study, the antioxidant, anti-inflammatory, and antitumor potentials of carvedilol was explored in a different approach. The cholesterol (CHO) was investigated as facilitated agent in the action of carvedilol-loaded nanoparticles. Different formulations exhibited spherical and stable nanoparticle with mean diameter size < 250 nm. The cholesterol changed the copolymer-drug interactions and the encapsulation efficiency. The in vitro cancer study was performed using murine colorectal cancer cell line (CT-26) to observe the cell viability and apoptosis on MTS assay and flow cytometry, respectively. The experiments have demonstrated that cholesterol improved the performance of drug-loaded nanoparticles, which was much better than free drug. The in vivo inflammation peritonitis model revealed that carvedilol-loaded nanoparticles increased the level of glutathione and leukocyte migration mainly when the functionalized drug-loaded nanoparticles were tested, in a lower dose than the free drug. As hypothesized, the experimental data suggest that cholesterol-functionalized carvedilol-loaded PLGA nanoparticles can be a novel and promising approach in the inflammation-induced cancer therapy since showed anti-inflammatory, antioxidant, and antitumor effects.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Inflammatory Biomarkers in Disease Prognosis · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Aboud HM, El Komy MH, Ali AA, El Menshawe SF, Abd Elbary A (2016) Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery AAPS. Pharm Sci Tech 17:1353–1365. https://doi.org/10.1208/s12249-015-0440-810.1208/s12249-015-0440-8 ↗
2. Alqahtani S et al (2015) Cellular uptake, antioxidant and antiproliferative activity of entrapped α-tocopherol and γ-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi). J Colloid Interface Sci 445:243–251. https://doi.org/10.1016/j.jcis.2014.12.08310.1016/j.jcis.2014.12.083 ↗
3. Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113:548–55510.1016/S0076-6879(85)13073-9 ↗
4. Araújo Júnior RF, Garcia VB, RFdC L, GAdC B, EdC M, PMM G, de Araújo AA (2016) Carvedilol improves inflammatory response, oxidative stress and fibrosis in the alcohol-induced liver injury in rats by regulating Kuppfer cells and hepatic stellate cells. PLoS One 11:e0148868. https://doi.org/10.1371/journal.pone.014886810.1371/journal.pone.0148868 ↗
5. Areti A, Komirishetty P, Kumar A (2017) Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy. Toxicol Appl Pharmacol 322:97–103. https://doi.org/10.1016/j.taap.2017.03.00910.1016/j.taap.2017.03.009 ↗
6. Astete CE, Dolliver D, Whaley M, Khachatryan L, Sabliov CM (2011) Antioxidant poly(lactic-co-glycolic) acid nanoparticles made with alpha-tocopherol-ascorbic acid surfactant. ACS Nano 5:9313–9325. https://doi.org/10.1021/nn102845t10.1021/nn102845t ↗
7. Baena-Aristizábal CM, Fessi H, Elaissari A, Mora-Huertas CE (2016) Biodegradable microparticles preparation by double emulsification—solvent extraction method: a systematic study. Colloids Surf A Physicochem Eng Asp 492:213–229. https://doi.org/10.1016/j.colsurfa.2015.11.06710.1016/j.colsurfa.2015.11.067 ↗
8. Bahrami B, Hojjat-Farsangi M, Mohammadi H, Anvari E, Ghalamfarsa G, Yousefi M, Jadidi-Niaragh F (2017) Nanoparticles and targeted drug delivery in cancer therapy. Immunol Lett 190:64–83. https://doi.org/10.1016/j.imlet.2017.07.01510.1016/j.imlet.2017.07.015 ↗
9. Balaha M, Kandeel S, Barakat W (2016) Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats. Toxicol Appl Pharmacol 311. https://doi.org/10.1016/j.taap.2016.10.01210.1016/j.taap.2016.10.012 ↗
10. Bazylińska U, Lewińska A, Lamch Ł, Wilk KA (2014) Polymeric nanocapsules and nanospheres for encapsulation and long sustained release of hydrophobic cyanine-type photosensitizer. Colloids Surf A Physicochem Eng Asp 442:42–49. https://doi.org/10.1016/j.colsurfa.2013.02.02310.1016/j.colsurfa.2013.02.023 ↗
11. Binder K, Virnau P, Statt A (2014) Perspective: the Asakura Oosawa model: a colloid prototype for bulk and interfacial phase behavior. J Chem Phys 141:140901. https://doi.org/10.1063/1.489694310.1063/1.4896943 ↗
12. Cheng Y, Morshed R, Auffinger B, Tobias AL, Lesniak MS (2014) Multifunctional nanoparticles for brain tumor diagnosis and therapy Adv Drug Deliv Rev 0:42–57 doi:https://doi.org/10.1016/j.addr.2013.09.006, 6610.1016/j.addr.2013.09.006 ↗
13. Choi DG, Venkatesan J, Shim MS (2019) Selective anticancer therapy using pro-oxidant drug-loaded chitosan-fucoidan nanoparticles. Int J Mol Sci 20:20. https://doi.org/10.3390/ijms2013322010.3390/ijms20133220 ↗
14. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867. https://doi.org/10.1038/nature0132210.1038/nature01322 ↗
15. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505–522. https://doi.org/10.1016/j.jconrel.2012.01.04310.1016/j.jconrel.2012.01.043 ↗
16. De Araujo RF Jr et al (2018) Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins. Int J Oncol 52:189–200. https://doi.org/10.3892/ijo.2017.417910.3892/ijo.2017.4179 ↗
17. de Oliveira AM, Jäger E, Jäger A, Stepánek P, Giacomelli FC (2013) Physicochemical aspects behind the size of biodegradable polymeric nanoparticles: a step forward. Colloids Surf A Physicochem Eng Asp 436:1092–1102. https://doi.org/10.1016/j.colsurfa.2013.08.05610.1016/j.colsurfa.2013.08.056 ↗
18. Doquet V, Barkia B (2016) Combined AFM, SEM and crystal plasticity analysis of grain boundary sliding in titanium at room temperature. Mech Mater:103–127. https://doi.org/10.1016/j.mechmat.2016.09.00110.1016/j.mechmat.2016.09.001 ↗
19. dos Santos Silva AM et al (2019) Hydrophilic and hydrophobic polymeric benznidazole-loaded nanoparticles: physicochemical properties and in vitro antitumor efficacy. Journal of Drug Delivery Science and Technology 51:700–707. https://doi.org/10.1016/j.jddst.2019.04.00510.1016/j.jddst.2019.04.005 ↗
20. dos Santos-Silva AM, de Caland LB, de ALC SLO, de Araújo-Júnior RF, Fernandes-Pedrosa MF, Cornélio AM, da Silva-Júnior AA (2017) Designing structural features of novel benznidazole-loaded cationic nanoparticles for inducing slow drug release and improvement of biological efficacy. Mater Sci Eng C 78:978–987. https://doi.org/10.1016/j.msec.2017.04.05310.1016/j.msec.2017.04.053 ↗
21. Dos Santos-Silva AM et al (2019) Self-assembled benznidazole-loaded cationic nanoparticles containing cholesterol/sialic acid: physicochemical properties, in vitro drug release and in vitro anticancer efficacy. Int J Mol Sci 20. https://doi.org/10.3390/ijms2009235010.3390/ijms20092350 ↗
22. El-Hammadi MM, Delgado ÁV, Melguizo C, Prados JC, Arias JL (2017) Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. Int J Pharm 516:61–70. https://doi.org/10.1016/j.ijpharm.2016.11.01210.1016/j.ijpharm.2016.11.012 ↗
23. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759–771. https://doi.org/10.1038/nrc361110.1038/nrc3611 ↗
24. El-Say K, Hosny KM, Alkhalidi H (2018) Quality by design approach to screen the formulation and process variables influencing the characteristics of carvedilol solid lipid nanoparticles. J Drug Deliv Sci Technol:45–168. https://doi.org/10.1016/j.jddst.2018.03.01010.1016/j.jddst.2018.03.010 ↗
25. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–42110.1016/0076-6879(90)86134-H ↗
26. Falcao TR et al (2018) Crude extract and fractions from Eugenia uniflora Linn leaves showed anti-inflammatory, antioxidant, and antibacterial activities. BMC Complement Altern Med 18:84. https://doi.org/10.1186/s12906-018-2144-610.1186/s12906-018-2144-6 ↗
27. Félix L et al (2017) Carvedilol exacerbate gentamicin-induced kidney mitochondrial alterations in adult rat. Exp Toxicol Pathol 69:83–92. https://doi.org/10.1016/j.etp.2016.11.00610.1016/j.etp.2016.11.006 ↗
28. Ghuman S et al (2017) Serum inflammatory markers and colorectal cancer risk and survival. Br J Cancer 116:1358–1365. https://doi.org/10.1038/bjc.2017.9610.1038/bjc.2017.96 ↗
29. Gocalinska A, Manganaro M, Dimastrodonato V, Pelucchi E (2015) Evaluation of defect density by top-view large scale AFM on metamorphic structures grown by MOVPEvol 349. doi:https://doi.org/10.1016/j.apsusc.2015.05.07010.1016/j.apsusc.2015.05.070 ↗
30. Goyal R, Macri LK, Kaplan HM, Kohn J (2016) Nanoparticles and nanofibers for topical drug delivery. J Control Release 240:77–92. https://doi.org/10.1016/j.jconrel.2015.10.04910.1016/j.jconrel.2015.10.049 ↗
31. Grouchko M, Roitman P, Zhu X, Popov I, Kamyshny A, Su H, Magdassi S (2014) Merging of metal nanoparticles driven by selective wettability of silver nanostructures. Nat Commun 5:2994. https://doi.org/10.1038/ncomms399410.1038/ncomms3994 ↗
32. Hans ML, Lowman A (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opinion Solid State Mater Sci 6:319. https://doi.org/10.1016/S1359-0286(02)00117-110.1016/S1359-0286(02)00117-1 ↗
33. Hoo CM, Starostin N, West P, Mecartney M (2008) A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distribution. J Nanopart Res 10. https://doi.org/10.1007/s11051-008-9435-710.1007/s11051-008-9435-7 ↗
34. Kapadia CH, Perry JL, Tian S, Luft JC, DeSimone JM (2015) Nanoparticulate immunotherapy for cancer. J Control Release 219:167–180. https://doi.org/10.1016/j.jconrel.2015.09.06210.1016/j.jconrel.2015.09.062 ↗
35. Kong ZL, Kuo HP, Johnson A, Wu LC, Chang KLB (2019) Curcumin-loaded mesoporous silica nanoparticles markedly enhanced cytotoxicity in hepatocellular carcinoma cells. Int J Mol Sci:20. https://doi.org/10.3390/ijms2012291810.3390/ijms20122918 ↗
36. Lee BK, Yun YH, Park K (2015) Smart nanoparticles for drug delivery: boundaries and opportunities. Chem Eng Sci 125:158–164. https://doi.org/10.1016/j.ces.2014.06.04210.1016/j.ces.2014.06.042 ↗
37. Lee J-J, Lee SY, Park J-H, Kim D-D, Cho H-J (2016) Cholesterol-modified poly(lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery. Int J Pharm 509:483–491. https://doi.org/10.1016/j.ijpharm.2016.06.00810.1016/j.ijpharm.2016.06.008 ↗
38. Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, Zhu Y (2018) Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol 107:204–211. https://doi.org/10.1016/j.ijbiomac.2017.08.15510.1016/j.ijbiomac.2017.08.155 ↗
39. Lin J, Zhang H, Chen Z, Zheng Y (2010) Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano 4:5421–5429. https://doi.org/10.1021/nn101079210.1021/nn1010792 ↗
40. Liu P et al (2015) Development of alendronate-conjugated poly (lactic-co-glycolic acid)-dextran nanoparticles for active targeting of cisplatin in osteosarcoma. Sci Rep 5:17387–17387. https://doi.org/10.1038/srep1738710.1038/srep17387 ↗
41. Luxenhofer R (2015) Polymers and nanomedicine: considerations on variability and reproducibility when combining complex systems. Nanomedicine (Lond) 10:3109–3119. https://doi.org/10.2217/nnm.15.13910.2217/nnm.15.139 ↗
42. Malich G, Markovic B, Winder C (1997) The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124:179–192. https://doi.org/10.1016/S0300-483X(97)00151-010.1016/S0300-483X(97)00151-0 ↗
43. Masloub SM, Elmalahy MH, Sabry D, Mohamed WS, Ahmed SH (2016) Comparative evaluation of PLGA nanoparticle delivery system for 5-fluorouracil and curcumin on squamous cell carcinoma. Arch Oral Biol 64:1–10. https://doi.org/10.1016/j.archoralbio.2015.12.00310.1016/j.archoralbio.2015.12.003 ↗
44. Mazumdar S, Italiya KS, Sharma S, Chitkara D, Mittal A (2018) Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of tamoxifen by cholesterol based lipopolymeric nanoparticles. Int J Pharm 543:96–106. https://doi.org/10.1016/j.ijpharm.2018.03.02210.1016/j.ijpharm.2018.03.022 ↗
45. Milling L, Zhang Y, Irvine DJ (2017) Delivering safer immunotherapies for cancer. Adv Drug Deliv Rev 114:79–101. https://doi.org/10.1016/j.addr.2017.05.01110.1016/j.addr.2017.05.011 ↗
46. Nallamuthu I, Parthasarathi A, Khanum F (2013) Thymoquinone-loaded PLGA nanoparticles: antioxidant and anti-microbial properties vol 2. doi:https://doi.org/10.3329/icpj.v2i12.1701710.3329/icpj.v2i12.17017 ↗
47. Némethová V et al (2017) Intracellular uptake of magnetite nanoparticles: a focus on physico-chemical characterization and interpretation of in vitro data. Mater Sci Eng C 70:161–168. https://doi.org/10.1016/j.msec.2016.08.06410.1016/j.msec.2016.08.064 ↗
48. Neupane YR, Srivastava M, Ahmad N, Kumar N, Bhatnagar A, Kohli K (2014) Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. Int J Pharm 477:601–612. https://doi.org/10.1016/j.ijpharm.2014.11.00110.1016/j.ijpharm.2014.11.001 ↗
49. Ng SF, Rouse JJ, Sanderson FD, Meidan V, Eccleston GM (2010) Validation of a static Franz diffusion cell system for in vitro permeation studies. AAPS PharmSciTech 11:1432–1441. https://doi.org/10.1208/s12249-010-9522-910.1208/s12249-010-9522-9 ↗
50. Pereira MC et al (2018) Effect of nanoencapsulation using PLGA on antioxidant and antimicrobial activities of guabiroba fruit phenolic extract. Food Chem 240:396–404. https://doi.org/10.1016/j.foodchem.2017.07.14410.1016/j.foodchem.2017.07.144 ↗
51. Pooja D, Tunki L, Kulhari H, Reddy BB, Sistla R (2016) Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method. Data Brief 6:15–19. https://doi.org/10.1016/j.dib.2015.11.03810.1016/j.dib.2015.11.038 ↗
52. Qi F, Zhang X, Li S (2013) A novel method to get methotrexatum/layered double hydroxides intercalation compounds and their release properties. J Phys Chem Solids 74:1101–1108. https://doi.org/10.1016/j.jpcs.2013.03.00510.1016/j.jpcs.2013.03.005 ↗
53. Ramalho MJ, Sevin E, Gosselet F, Lima J, Coelho MAN, Loureiro JA, Pereira MC (2018) Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. Int J Pharm 545:84–92. https://doi.org/10.1016/j.ijpharm.2018.04.06210.1016/j.ijpharm.2018.04.062 ↗
54. Ramezanpour M, Leung SSW, Delgado-Magnero KH, Bashe BYM, Thewalt J, Tieleman DP (2016) Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim Biophys Acta Biomembr 1858:1688–1709. https://doi.org/10.1016/j.bbamem.2016.02.02810.1016/j.bbamem.2016.02.028 ↗
55. Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH (1991) IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 73:472–477
56. Son S, Kim WJ (2010) Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials 31:133–143. https://doi.org/10.1016/j.biomaterials.2009.09.02410.1016/j.biomaterials.2009.09.024 ↗
57. Taniguchi K, Karin M (2018) NF-kappaB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18:309–324. https://doi.org/10.1038/nri.2017.14210.1038/nri.2017.142 ↗
58. Varan G, Öncül S, Ercan A, Benito JM, Ortiz Mellet C, Bilensoy E (2016) Cholesterol-targeted anticancer and apoptotic effects of anionic and polycationic amphiphilic cyclodextrin nanoparticles. J Pharm Sci 105:3172–3182. https://doi.org/10.1016/j.xphs.2016.06.02110.1016/j.xphs.2016.06.021 ↗
59. Venishetty VK, Chede R, Komuravelli R, Adepu L, Sistla R, Diwan PV (2012) Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B: Biointerfaces 95:1–9. https://doi.org/10.1016/j.colsurfb.2012.01.00110.1016/j.colsurfb.2012.01.001 ↗
60. Waghela BN, Sharma A, Dhumale S, Pandey SM, Pathak C (2015) Curcumin conjugated with PLGA potentiates sustainability, anti-proliferative activity and apoptosis in human colon carcinoma cells. PLoS One 10:e0117526–e0117526. https://doi.org/10.1371/journal.pone.011752610.1371/journal.pone.0117526 ↗
61. Wang W, Chen T, Xu H, Ren B, Cheng X, Qi R, Liu H, Wang Y, Yan L, Chen S, Yang Q, Chen C (2018) Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer. Molecules:23. https://doi.org/10.3390/molecules2307157810.3390/molecules23071578 ↗
62. West NR, McCuaig S, Franchini F, Powrie F (2015) Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 15:615–629. https://doi.org/10.1038/nri389610.1038/nri3896 ↗
63. Yao K, Zhang WW, Yao L, Yang S, Nie W, Huang F (2016) Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1/TFAM pathway in human umbilical vein endothelial cells (HUVECs). Biochem Biophys Res Commun 470:961–966. https://doi.org/10.1016/j.bbrc.2016.01.08910.1016/j.bbrc.2016.01.089 ↗
64. Zhu M, Shi J, He Q, Zhang L, Chen F, Chen Y (2012) An emulsification-solvent evaporation route to mesoporous bioactive glass microspheres for bisphosphonate drug delivery. J Mater Sci 47:2256. https://doi.org/10.1007/s10853-011-6037-z10.1007/s10853-011-6037-z ↗